‘Too early’ to say how Purdue Pharma deal will impact Baton Rouge opioid lawsuit

    Purdue Pharma, the maker of OxyContin, has filed for bankruptcy as part of a planned $10 billion agreement to settle thousands of lawsuits over its role in the nation’s opioid crisis. But it’s …


    Already an INSIDER? Sign in.